Advertisement

Cardiovascular Engineering and Technology

, Volume 6, Issue 3, pp 220–229 | Cite as

Establishing the Framework for Tissue Engineered Heart Pumps

  • Mohamed A. Mohamed
  • Matt K. Hogan
  • Nikita M. Patel
  • Ze-Wei Tao
  • Laura Gutierrez
  • Ravi K. BirlaEmail author
Article

Abstract

Development of a natural alternative to cardiac assist devices (CADs) will pave the way to a heart failure therapy which overcomes the disadvantages of current mechanical devices. This work provides the framework for fabrication of a tissue engineered heart pump (TEHP). Artificial heart muscle (AHM) was first fabricated by culturing 4 million rat neonatal cardiac cells on the surface of a fibrin gel. To form a TEHP, AHM was wrapped around an acellular goat carotid artery (GCA) and a chitosan hollow cylinder (CHC) scaffold with either the cardiac cells directly contacting the construct periphery or separated by the fibrin gel. Histology revealed the presence of cardiac cell layer cohesion and adhesion to the fibrin gel scaffold, acellular GCA, and synthesized CHC. Expression of myocytes markers, connexin43 and α-actinin, was also noted. Biopotential measurements revealed the presence of ~2.5 Hz rhythmic propagation of action potential throughout the TEHP. Degradation of the fibrin gel scaffold of the AHM via endogenous proteases may be used as a means of delivering the cardiac cells to cylindrical scaffolds. Further development of the TEHP model by use of multi-stimulus bioreactors may lead to the application of bioengineered CADs.

Keywords

Tissue engineering Cardiac pumps Heart failure Cell culture Cardiac assist devices 

Notes

Acknowledgments

The researchers would like to acknowledge NIH for provision of funding for this research. We would also like to thank the Department of Biomedical Engineering and the Cullen College of Engineering at University of Houston for further financial support.

Conflict of interest

Research was funded by NIH (Grant number: R01-EB011516).

Statement of Human Studies

No human studies were carried out by the authors for this article.

Statement of Animal Studies

Approval for animal use was granted by the Institutional Animal Care and Use Committee (IACUC) at the University of Houston, in accordance with the “Guide for the Care and Use of Laboratory Animals” (NIH publication 86-23, 1996).

Supplementary material

Supplementary material 1 (AVI 1090 kb)

Supplementary material 2 (AVI 781 kb)

References

  1. 1.
    Ahmed, T. A. E., E. V. Dare, and M. Hincke. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng. Part B. Rev. 14:199–215, 2008.CrossRefGoogle Scholar
  2. 2.
    Anversa, P., J. Kajstura, M. Rota, and A. Leri. Regenerating new heart with stem cells. J. Clin. Invest. 123:62–70, 2013.CrossRefGoogle Scholar
  3. 3.
    Barsotti, M. C., F. Felice, A. Balbarini, and R. Di Stefano. Fibrin as a scaffold for cardiac tissue engineering. Biotechnol. Appl. Biochem. 58:301–310, 2011.CrossRefGoogle Scholar
  4. 4.
    Birla, R. K., D. E. Dow, Y.-C. Huang, F. Migneco, L. Khait, G. H. Borschel, et al. Methodology for the formation of functional, cell-based cardiac pressure generation constructs in vitro. In Vitro Cell. Dev. Biol. Anim. 44:340–350, 2008.CrossRefGoogle Scholar
  5. 5.
    Camelliti, P., T. K. Borg, and P. Kohl. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 65:40–51, 2005.CrossRefGoogle Scholar
  6. 6.
    Cereghetti, C., C. Kaiser, and S. Cook. Ventricular assist devices in acute heart failure. Minerva Cardioangiol. 60:395–403, 2012.Google Scholar
  7. 7.
    Cohn, L. H. The role of mechanical devices. J. Card. Surg. 5:278–281, 1990.CrossRefGoogle Scholar
  8. 8.
    Engin, C., F. Ayik, E. Oguz, B. Eygi, T. Yagdi, S. Karakula, et al. Ventricular assist device as a bridge to heart transplantation in adults. Transplant. Proc. 43:927–930, 2011.CrossRefGoogle Scholar
  9. 9.
    Frazier, O. H. New technologies in the treatment of severe cardiac failure: the Texas Heart Institute experience. Ann. Thorac. Surg. 59:S31–S37, 1995; ((Discussion S38)).CrossRefGoogle Scholar
  10. 10.
    Fujimoto, K. L., K. C. Clause, L. J. Liu, J. P. Tinney, S. Verma, W. R. Wagner, et al. Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function. Tissue Eng. Part A 17:585–596, 2011.CrossRefGoogle Scholar
  11. 11.
    Gandaglia, A., R. Huerta-Cantillo, M. Comisso, R. Danesin, F. Ghezzo, F. Naso, et al. Cardiomyocytes in vitro adhesion is actively influenced by biomimetic synthetic peptides for cardiac tissue engineering. Tissue Eng. Part A 18:725–736, 2012.CrossRefGoogle Scholar
  12. 12.
    Gilbert, T. W., T. L. Sellaro, and S. F. Badylak. Decellularization of tissues and organs. Biomaterials 27:3675–3683, 2006.Google Scholar
  13. 13.
    Hecker, L., L. Khait, D. Radnoti, and R. Birla. Novel bench-top perfusion system improves functional performance of bioengineered heart muscle. J. Biosci. Bioeng. 107:183–190, 2009.CrossRefGoogle Scholar
  14. 14.
    Huang, Y.-C., L. Khait, and R. K. Birla. Contractile three-dimensional bioengineered heart muscle for myocardial regeneration. J. Biomed. Mater. Res. A. 80:719–731, 2007.CrossRefGoogle Scholar
  15. 15.
    Khait, L., and R. K. Birla. Cell-based cardiac pumps and tissue-engineered ventricles. Regen. Med. 2:391–406, 2007.CrossRefGoogle Scholar
  16. 16.
    Kubo, H., T. Shimizu, M. Yamato, T. Fujimoto, and T. Okano. Creation of myocardial tubes using cardiomyocyte sheets and an in vitro cell sheet-wrapping device. Biomaterials 28:3508–3516, 2007.CrossRefGoogle Scholar
  17. 17.
    Kupcsik, L., M. Alini, and M. J. Stoddart. Epsilon-aminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering. Tissue Eng. Part A 15:2309–2313, 2009.CrossRefGoogle Scholar
  18. 18.
    Melchiorri, A. J., N. Hibino, and J. P. Fisher. Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts. Tissue Eng. Part B. Rev. 19:292–307, 2013.CrossRefGoogle Scholar
  19. 19.
    Tao, Z.-W., M. Mohamed, M. Hogan, L. Gutierrez, and R. K. Birla. Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel. J. Tissue Eng. Regen. Med. 2014. doi: 10.1002/term.1895.
  20. 20.
    Villalona, G. A., B. Udelsman, D. R. Duncan, E. McGillicuddy, R. F. Sawh-Martinez, N. Hibino, et al. Cell-seeding techniques in vascular tissue engineering. Tissue Eng. Part B. Rev. 16:341–350, 2010.CrossRefGoogle Scholar

Copyright information

© Biomedical Engineering Society 2015

Authors and Affiliations

  • Mohamed A. Mohamed
    • 1
  • Matt K. Hogan
    • 1
  • Nikita M. Patel
    • 1
  • Ze-Wei Tao
    • 1
  • Laura Gutierrez
    • 1
  • Ravi K. Birla
    • 1
    Email author
  1. 1.Department of Biomedical Engineering, Cullen College of EngineeringUniversity of HoustonHoustonUSA

Personalised recommendations